Getein Biotech, Inc (SHA:603387)
China
· Delayed Price · Currency is CNY 8.04
+0.04 (0.50%)
Apr 24, 2025, 2:45 PM CST
Getein Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Net Income | 252.99 | 279.77 | 498.91 | 398.99 | 304.73 | 339.67 | Upgrade
|
| Depreciation & Amortization | 91.73 | 91.73 | 70.35 | 49.4 | 35.93 | 27.94 | Upgrade
|
| Other Amortization | 10.12 | 10.12 | 7.79 | 7.13 | 6.02 | 5.7 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.67 | -0.67 | -0.02 | -1.05 | -0.57 | -0.52 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.69 | 1.69 | 0.53 | 0.1 | - | 1.49 | Upgrade
|
| Loss (Gain) From Sale of Investments | -26.31 | -26.31 | -34.63 | -23.56 | -42.54 | -28.42 | Upgrade
|
| Provision & Write-off of Bad Debts | 19.21 | 19.21 | 22.87 | 8.36 | 12.48 | - | Upgrade
|
| Other Operating Activities | 159.95 | 29.77 | 37.37 | 31.26 | 41.59 | 10.91 | Upgrade
|
| Change in Accounts Receivable | -2.45 | -2.45 | -111.25 | -49.52 | -200.29 | -163.87 | Upgrade
|
| Change in Inventory | 17.34 | 17.34 | -52.25 | -43.27 | -40.26 | -35.8 | Upgrade
|
| Change in Accounts Payable | -81.06 | -81.06 | 53.6 | 56.13 | 60.29 | 54.24 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | 2.89 | 7.43 | Upgrade
|
| Operating Cash Flow | 436.62 | 333.22 | 482.96 | 432.36 | 185.47 | 225.73 | Upgrade
|
| Operating Cash Flow Growth | 3.57% | -31.00% | 11.70% | 133.12% | -17.84% | 20.65% | Upgrade
|
| Capital Expenditures | -151.41 | -258.13 | -217.44 | -179.6 | -113.53 | -124.82 | Upgrade
|
| Sale of Property, Plant & Equipment | 7.76 | 8.65 | 4.57 | 2.87 | 4.16 | 8.69 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -54.05 | - | Upgrade
|
| Divestitures | 2.74 | 3.23 | - | - | - | - | Upgrade
|
| Investment in Securities | 11.69 | -119.8 | -586.57 | -104.75 | -99.41 | 348.73 | Upgrade
|
| Other Investing Activities | 14.16 | 9.22 | 39 | 26.84 | 24.12 | 29.16 | Upgrade
|
| Investing Cash Flow | -115.06 | -356.83 | -760.44 | -254.63 | -238.71 | 261.76 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 0.79 | - | Upgrade
|
| Long-Term Debt Issued | - | 1,130 | 792.44 | 496.63 | 635.82 | 135 | Upgrade
|
| Total Debt Issued | 999.4 | 1,130 | 792.44 | 496.63 | 636.6 | 135 | Upgrade
|
| Long-Term Debt Repaid | - | -1,062 | -707.06 | -380.89 | -365.33 | -40 | Upgrade
|
| Net Debt Issued (Repaid) | -35.37 | 67.92 | 85.39 | 115.74 | 271.27 | 95 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 45.51 | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | -50.38 | -0.54 | -0.54 | Upgrade
|
| Common Dividends Paid | -110.12 | -219.4 | -140.73 | -103.57 | -115.82 | -77.85 | Upgrade
|
| Other Financing Activities | -15.4 | 5.61 | 9.46 | 9.28 | -0.41 | 9.32 | Upgrade
|
| Financing Cash Flow | -160.89 | -145.88 | -45.88 | -28.93 | 200 | 25.94 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.65 | 11.67 | 19.2 | -1.02 | -6.04 | 0.81 | Upgrade
|
| Net Cash Flow | 160.03 | -157.81 | -304.16 | 147.78 | 140.72 | 514.24 | Upgrade
|
| Free Cash Flow | 285.21 | 75.09 | 265.51 | 252.77 | 71.94 | 100.92 | Upgrade
|
| Free Cash Flow Growth | 125.38% | -71.72% | 5.04% | 251.38% | -28.72% | 32.17% | Upgrade
|
| Free Cash Flow Margin | 22.85% | 5.49% | 14.57% | 18.03% | 6.40% | 10.42% | Upgrade
|
| Free Cash Flow Per Share | 0.56 | 0.15 | 0.52 | 0.49 | 0.14 | 0.20 | Upgrade
|
| Cash Income Tax Paid | 112.1 | 148.48 | 123.19 | 148.32 | 97.53 | 136.03 | Upgrade
|
| Levered Free Cash Flow | 752.55 | -68.01 | -269.29 | 115.56 | -102.12 | 875.5 | Upgrade
|
| Unlevered Free Cash Flow | 761.87 | -57.42 | -258.91 | 124.51 | -98.23 | 876.4 | Upgrade
|
| Change in Net Working Capital | -668.95 | 33.79 | 430.24 | 8.42 | 220.47 | -748.94 | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.